Litcius/Paper detail

Incidence, Risk Factors, and Outcomes of BK Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplantation From HLA-Matched and Haploidentical Donors With Post-Transplant Cyclophosphamide

Pedro Chorão, Marta Villalba, Aitana Balaguer‐Roselló, Juan Montoro, Pablo Granados, C Rodríguez Gilabert, Francisca Panadero, André Airosa Pardal, Eva González, Santiago de Cossio, Rafael Benavente, María Dolores Gómez, Inés Gómez‐Seguí, Pilar Solves, Marta Santiago, Pedro Asensi Cantó, Pilar Lloret Madrid, Juan Eirís, David Martínez, Alberto Louro, Paula Rebollar, Aurora Perla, Miguel Salavert, Javier de la Rubia, Miguel Á. Sanz, Jaime Sanz

2024Transplantation and Cellular Therapy13 citationsDOI

Topics & Concepts

Hemorrhagic cystitisHuman leukocyte antigenMedicineHematopoietic stem cell transplantationIncidence (geometry)CyclophosphamideImmunologyTransplantationStem cellOncologyInternal medicineChemotherapyAntigenBiologyGeneticsOpticsPhysicsPolyomavirus and related diseases
Incidence, Risk Factors, and Outcomes of BK Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplantation From HLA-Matched and Haploidentical Donors With Post-Transplant Cyclophosphamide | Litcius